Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries
Sang Gune K. Yoo(Washington University in St. Louis), David Flood(Institute of Nutrition of Central America and Panama), Peter Rohloff(Brigham and Women's Hospital), Maja E. Marcus(University of Göttingen), Justine Davies(Western Cape Department of Health), Michaela Theilmann(Brigham and Women's Hospital), Mohammadreza Azangou‐Khyavy(Gomal University), Mongal Singh Gurung, Krishna Kumar Aryal(Abt Associates (Nepal)), Lela Sturua(National Center for Disease Control and Public Health), Farshad Farzadfar(Tehran University of Medical Sciences), Rosa Haghshenas(Tehran University of Medical Sciences), Corine Houéhanou(Université de Parakou), Болормаа Норов(National Center for Communicable Diseases), Silver Bahendeka(Nsambya Hospital), João Martins(Universidade da Paz), Kavita Singh(Jawaharlal Nehru University), David Guwatudde(Makerere University), Sahar Saeedi Moghaddam(Kiel Institute for the World Economy), Pascal Geldsetzer(Stanford University), Luísa Campos Caldeira Brant(University of Washington), Mark D. Huffman(Northwestern University), Jennifer Manne‐Goehler(Brigham and Women's Hospital), Renata Cífková(Brigham and Women's Hospital), Abla Mehio Sibai(American University of Beirut), Grace S. Chung(New Mexico Department of Health), Khem Bahadur Karki(Tribhuvan University), Nuno Lunet(Universidade do Porto), Sebastián Vollmer(University of Göttingen), Joseph Kibachio Mwangi(Ministry of Health), Rifat Atun(Harvard University), Till Bärnighausen(Harvard University), Albertino Damasceno(Universidade do Porto), Jeremy B. Sussman(University of Michigan)
Cited by 25
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k